<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB01755</drugbank-id>
  <drugbank-id>EXPT01859</drugbank-id>
  <name>N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone</name>
  <description/>
  <cas-number/>
  <unii/>
  <average-mass>458.493</average-mass>
  <monoisotopic-mass>458.169601294</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as 5'-deoxyribonucleosides. These are nucleosides in which the oxygen atom at the 5'position of the ribose moiety has been replaced by another atom. The nucleobases here are limited to purine, pyrimidine, and pyridine derivatives.</description>
    <direct-parent>5'-deoxyribonucleosides</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Nucleosides, nucleotides, and analogues</superclass>
    <class>5'-deoxyribonucleosides</class>
    <subclass/>
    <alternative-parent>1,2-diols</alternative-parent>
    <alternative-parent>6-aminopurines</alternative-parent>
    <alternative-parent>Aminopyrimidines and derivatives</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Glycosylamines</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Imidolactams</alternative-parent>
    <alternative-parent>Isoleucine and derivatives</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>N-substituted imidazoles</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organic sulfuric acids and derivatives</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Oxacyclic compounds</alternative-parent>
    <alternative-parent>Pentoses</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Tetrahydrofurans</alternative-parent>
    <substituent>1,2-diol</substituent>
    <substituent>5'-deoxyribonucleoside</substituent>
    <substituent>6-aminopurine</substituent>
    <substituent>Alcohol</substituent>
    <substituent>Alpha-amino acid or derivatives</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid or derivatives</substituent>
    <substituent>Aminopyrimidine</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Azole</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Glycosyl compound</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Imidazole</substituent>
    <substituent>Imidazopyrimidine</substituent>
    <substituent>Imidolactam</substituent>
    <substituent>Isoleucine or derivatives</substituent>
    <substituent>Monosaccharide</substituent>
    <substituent>N-glycosyl compound</substituent>
    <substituent>N-substituted imidazole</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organic sulfuric acid or derivatives</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Oxacycle</substituent>
    <substituent>Pentose monosaccharide</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Purine</substituent>
    <substituent>Pyrimidine</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Tetrahydrofuran</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">5'-Deoxy-5'-[(L-isoleucylsulfamoyl)amino]adenosine</synonym>
  </synonyms>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms/>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1jzq</pdb-entry>
    <pdb-entry>4cqn</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-3.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S,3S)-2-amino-N-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfamoyl)-3-methylpentanamide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>4-[(2S)-2-{[(3S)-1-{[1,1'-biphenyl]-4-ylmethyl}-2-oxoazepan-3-yl]carbamoyl}-2-acetamidoethyl]-2-phosphonophenoxyacetic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>458.493</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>458.169601294</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[H]N([H])[C@@H]([C@@H](C)CC)C(=O)N([H])S(=O)(=O)N([H])C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N=CN=C12)N([H])[H]</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C16H26N8O6S</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C16H26N8O6S/c1-3-7(2)9(17)15(27)23-31(28,29)22-4-8-11(25)12(26)16(30-8)24-6-21-10-13(18)19-5-20-14(10)24/h5-9,11-12,16,22,25-26H,3-4,17H2,1-2H3,(H,23,27)(H2,18,19,20)/t7-,8+,9-,11+,12+,16+/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>XVTRBLLRODNOJV-VBJYJYTRSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>220.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>107.69</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>46.01</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>3.57</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>7.99</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>446595</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508937</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>393913</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>ILA</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0001372</id>
      <name>Isoleucine--tRNA ligase</name>
      <organism>Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P56690" source="Swiss-Prot">
        <name>Isoleucine--tRNA ligase</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS can inadvertently accommodate and process structurally similar amino acids such as valine, to avoid such errors it has two additional distinct tRNA(Ile)-dependent editing activities. One activity is designated as 'pretransfer' editing and involves the hydrolysis of activated Val-AMP. The other activity is designated 'posttransfer' editing and involves deacylation of mischarged Val-tRNA(Ile) (By similarity).</specific-function>
        <gene-name>ileS</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.23</theoretical-pi>
        <molecular-weight>119245.62</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="300852">Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AP008226</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>55772449</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P56690</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SYI_THET8</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.1.1.5</synonym>
          <synonym>IleRS</synonym>
          <synonym>Isoleucyl-tRNA synthetase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010960|Isoleucine--tRNA ligase
MFKEVGEPNFPKLEEEVLAFWKREKIFQKSVENRKGGPRYTVYEGPPTANGLPHVGHAQA
RSYKDLFPRYKTMRGYYAPRRAGWDTHGLPVELEVEKKLGLKSKREIEAYGIERFNQACR
ESVFTYEKEWEAFTERIAYWVDLENAYATLEPTYIESIWWSLKNLFDRGLLYRDHKVVPY
CPRCGTPLSSHEVALGYKEIQDPSVYVRFPLKEPKKLGLEKASLLIWTTTPWTLPGNVAA
AVHPEYTYAAFQVGDEALILEEGLGRKLLGEGTPVLKTFPGKALEGLPYTPPYPQALEKG
YFVVLADYVSQEDGTGIVHQAPAFGAEDLETARVYGLPLLKTVDEEGKLLVEPFKGLYFR
EANRAILRDLRGRGLLFKEESYLHSYPHCWRCSTPLMYYATESWFIKNTLFKDELIRKNQ
EIHWVPPHIKEGRYGEWLKNLVDWALSRNRYWGTPLPIWVCQACGKEEAIGSFQELKARA
TKPLPEPFDPHRPYVDQVELACACGGTMRRVPYVIDVWYDSGAMPFASLHYPFEHEEVFR
ESFPADFIAEGIDQTRGWFNSLHQLGVMLFGSIAFKNVICHGLILDEKGQKMSKSKGNVV
DPWDIIREFGADALRWYIYVSAPPEADRRFGPNLVRETVRDYFLTLWNVYSFFVTYANLD
RPDLKNPPPPEKRPEMDRWLLARMQDLIQRVTEALEAYDPTTSARALRDFVVEDLSQWYV
RRNRRRFWKNEDALDREAAYATLYEALVLVATLAAPFTPFLAEVLWQNLVRSVRPEAKES
VHLADWPEADPALADEALVAQMRAVLKVVDLARAARAKSGVKTRTPLPLLLVTAPTALER
EGLKRFAHEIAEELNVKEVRVLEPGEEILSYRVLPNLKLLGRKYGKLVPKIREALQRERE
RAAALALKGEAIPLEVEGEALTLLPEEVLLEAEAPKGYQALEKDGYVAALKVEVTEALRM
EGLARDLIRLLQQARKDMGLKVSDRIRVGYEAEGPYLEALKRHGPWIAEEVLATAFGEGL
FGGFEARVEDEEGKAVFHLARAE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010961|Isoleucine--tRNA ligase (ileS)
ATGTTCAAGGAGGTCGGCGAGCCCAACTTTCCCAAGCTGGAAGAGGAGGTCTTGGCCTTC
TGGAAGCGGGAAAAGATCTTCCAAAAGAGCGTGGAAAACCGCAAAGGCGGTCCCCGCTAC
ACCGTCTACGAGGGCCCTCCCACCGCCAACGGCCTCCCCCACGTGGGCCACGCCCAGGCC
CGGAGCTACAAGGACCTCTTCCCCCGCTACAAGACCATGCGGGGCTACTACGCGCCCCGG
AGGGCAGGCTGGGACACCCACGGGCTTCCCGTGGAGCTGGAGGTGGAGAAGAAGCTCGGC
CTCAAGAGCAAGCGGGAGATTGAGGCCTACGGCATTGAGCGCTTCAACCAAGCCTGCCGC
GAGTCCGTCTTCACCTACGAGAAGGAGTGGGAGGCCTTTACCGAGCGCATCGCCTACTGG
GTGGACCTGGAGAACGCCTACGCCACCTTGGAACCCACCTATATTGAGAGCATCTGGTGG
AGCCTGAAGAACCTCTTTGACCGGGGCCTCCTCTACCGGGACCACAAGGTGGTGCCCTAC
TGCCCCCGCTGCGGCACCCCCCTCTCCTCCCACGAGGTCGCCCTGGGGTACAAGGAGATC
CAAGACCCCTCGGTCTACGTCCGCTTCCCCTTGAAGGAGCCGAAGAAGCTTGGCCTAGAG
AAGGCGAGCCTCCTCATCTGGACCACCACCCCCTGGACCCTGCCCGGGAACGTGGCCGCA
GCAGTCCACCCGGAGTACACCTACGCCGCCTTCCAGGTGGGAGACGAGGCCCTGATCCTG
GAGGAGGGGCTGGGGAGGAAGCTTTTGGGCGAGGGAACCCCGGTCCTCAAAACCTTCCCG
GGCAAGGCCCTGGAAGGCCTCCCCTACACCCCCCCCTACCCCCAGGCCTTGGAGAAGGGC
TACTTCGTGGTCCTCGCCGACTACGTGAGTCAAGAGGACGGGACGGGCATCGTCCACCAG
GCCCCCGCCTTCGGCGCCGAGGACCTGGAGACGGCGAGGGTCTACGGGCTTCCCCTCCTG
AAGACCGTGGACGAGGAGGGGAAGCTCCTCGTGGAGCCGTTTAAGGGCCTCTACTTCCGC
GAGGCCAACCGGGCGATCCTAAGGGACCTGAGGGGGCGGGGCCTCCTCTTCAAGGAGGAA
AGCTACCTCCACAGCTACCCCCACTGCTGGCGGTGCTCCACCCCCCTCATGTACTACGCC
ACGGAGAGCTGGTTCATCAAAAACACCCTCTTCAAGGACGAGCTCATCCGCAAGAACCAG
GAGATCCACTGGGTGCCCCCCCACATCAAGGAGGGCCGCTACGGGGAGTGGCTCAAGAAC
CTCGTGGACTGGGCCTTAAGCCGCAACCGCTACTGGGGGACACCCCTCCCCATCTGGGTC
TGCCAGGCGTGCGGCAAGGAGGAGGCCATCGGGAGCTTCCAGGAGCTCAAGGCGAGGGCC
ACGAAGCCCCTCCCCGAGCCCTTTGACCCCCACCGCCCCTACGTGGACCAGGTGGAGCTC
GCCTGTGCCTGCGGCGGGACCATGCGCCGCGTCCCCTACGTCATTGACGTCTGGTACGAC
TCCGGGGCCATGCCCTTCGCCTCCTTGCACTACCCCTTTGAGCACGAAGAGGTGTTCCGG
GAGAGCTTCCCCGCGGACTTCATCGCCGAGGGGATTGACCAGACCCGGGGCTGGTTCAAC
TCCCTCCACCAGCTCGGGGTGATGCTCTTCGGCTCCATCGCCTTCAAGAACGTGATCTGC
CACGGCCTCATCCTGGACGAAAAGGGGCAGAAGATGTCCAAGTCCAAGGGGAACGTGGTG
GACCCCTGGGACATCATCCGGGAGTTCGGGGCGGACGCCCTCAGGTGGTACATCTACGTC
TCCGCGCCTCCCGAGGCCGACCGGCGCTTCGGGCCCAACCTGGTTCGGGAAACGGTGCGG
GACTACTTCCTCACCCTCTGGAACGTCTACAGCTTCTTCGTGACCTACGCCAACCTGGAC
CGGCCCGACCTCAAGAACCCCCCTCCCCCCGAGAAGCGGCCCGAGATGGACCGCTGGCTC
CTCGCCCGCATGCAGGACCTCATCCAGAGGGTGACGGAGGCCCTCGAGGCCTACGACCCC
ACCACGAGCGCCCGCGCCCTGAGGGACTTCGTGGTGGAGGACCTCTCCCAGTGGTACGTC
CGCAGGAACCGGCGCCGCTTCTGGAAGAACGAGGACGCCCTGGACCGGGAGGCGGCCTAC
GCCACCCTCTACGAGGCCCTCGTCCTGGTGGCCACCCTCGCCGCCCCCTTCACCCCCTTC
CTCGCCGAGGTCCTGTGGCAGAACCTGGTGCGGAGCGTCCGGCCCGAGGCCAAGGAGAGC
GTCCACCTCGCCGACTGGCCCGAGGCCGACCCGGCCCTGGCCGACGAGGCCCTGGTGGCC
CAGATGCGGGCGGTGCTCAAGGTGGTGGACCTGGCCCGGGCGGCCCGGGCGAAAAGCGGG
GTCAAGACCCGCACCCCCCTTCCCCTCCTCCTCGTCACCGCCCCCACCGCCTTGGAGCGG
GAGGGGTTAAAGCGCTTCGCCCACGAGATCGCCGAGGAGCTCAACGTCAAGGAGGTCCGG
GTCCTGGAACCCGGGGAGGAGATCCTCTCCTACAGGGTCCTGCCCAACCTCAAGCTCCTG
GGGAGGAAGTACGGCAAGCTCGTCCCCAAAATCCGGGAGGCCCTGCAAAGGGAAAGGGAG
CGCGCCGCCGCCTTGGCGCTTAAGGGCGAGGCCATCCCCCTGGAGGTGGAGGGCGAGGCC
CTCACCCTCCTCCCGGAGGAGGTCCTCCTCGAGGCCGAGGCCCCCAAGGGCTACCAGGCC
CTGGAGAAGGACGGGTACGTGGCCGCCCTCAAGGTGGAGGTCACGGAAGCCCTCCGCATG
GAGGGCCTCGCCCGCGACCTCATCCGCCTCCTGCAGCAGGCCCGCAAAGACATGGGCCTC
AAGGTCTCGGACCGGATCCGGGTGGGCTACGAGGCGGAGGGCCCCTACCTCGAGGCCCTG
AAGCGGCACGGGCCCTGGATCGCCGAGGAGGTGCTGGCCACCGCCTTCGGGGAAGGCCTC
TTCGGCGGGTTTGAGGCCCGGGTGGAGGACGAGGAGGGCAAGGCGGTCTTCCACCTGGCC
CGGGCGGAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08264</identifier>
            <name>Anticodon_1</name>
          </pfam>
          <pfam>
            <identifier>PF00133</identifier>
            <name>tRNA-synt_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>aminoacyl-tRNA editing activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>isoleucine-tRNA ligase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>isoleucyl-tRNA aminoacylation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>